̽»¨¾«Ñ¡

Research group leader for Neuroradiology focusing on Neurodegenerative and Neuroinflammatory disorders.  

After graduating from ̽»¨¾«Ñ¡ school at ̽»¨¾«Ñ¡ (KI) in 2012, I undertook a two-year clinical internship at VästerÃ¥s Regional Hospital.  

Academically, I started conducting MRI research in 2009, writing my ̽»¨¾«Ñ¡ thesis on the topic of MRI detection of Cerebral microbleeds in Alzheimer's disease using Susceptibility-Weighted Imaging. My PhD focused on , which I defended in 2015. I thereafter conducted a post-doctoral research fellowship at Massachusetts General Hospital and Harvard Medical School. My post-doctoral work focused on MS diagnostics using a combination of 7 Tesla MRI, 11C-PBR28 (2nd generation TSPO marker for microglia) PET-MR and Human Connectom Scanner with 300 mT/m gradients (compared to typical 40-80 mT/m clinical gradients). I also continued my work in developing and validating myelin quantification techniques.  

Upon my return to Karolinska, I established our research group at the Clinical Neuroscience department at KI, where we continue to focus on Quantitative imaging techniques and their applications to improve the diagnostics, prognostics and treatment evaluation in pathologies such as MS, dementia disorders, movement disorders and ALS.